293 related articles for article (PubMed ID: 14625550)
1. Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice.
Aoki K; Tamai Y; Horiike S; Oshima M; Taketo MM
Nat Genet; 2003 Dec; 35(4):323-30. PubMed ID: 14625550
[TBL] [Abstract][Full Text] [Related]
2. Suppression of colonic polyposis by homeoprotein CDX2 through its nontranscriptional function that stabilizes p27Kip1.
Aoki K; Kakizaki F; Sakashita H; Manabe T; Aoki M; Taketo MM
Cancer Res; 2011 Jan; 71(2):593-602. PubMed ID: 21224344
[TBL] [Abstract][Full Text] [Related]
3. CDX transcription factors positively regulate expression of solute carrier family 5, member 8 in the colonic epithelium.
Kakizaki F; Aoki K; Miyoshi H; Carrasco N; Aoki M; Taketo MM
Gastroenterology; 2010 Feb; 138(2):627-35. PubMed ID: 19900445
[TBL] [Abstract][Full Text] [Related]
4. Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice.
Xiao H; Yin W; Khan MA; Gulen MF; Zhou H; Sham HP; Jacobson K; Vallance BA; Li X
Gastroenterology; 2010 Aug; 139(2):574-85. PubMed ID: 20416302
[TBL] [Abstract][Full Text] [Related]
5. No effects of Smad2 (madh2) null mutation on malignant progression of intestinal polyps in Apc(delta716) knockout mice.
Takaku K; Wrana JL; Robertson EJ; Taketo MM
Cancer Res; 2002 Aug; 62(16):4558-61. PubMed ID: 12183405
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal instability by beta-catenin/TCF transcription in APC or beta-catenin mutant cells.
Aoki K; Aoki M; Sugai M; Harada N; Miyoshi H; Tsukamoto T; Mizoshita T; Tatematsu M; Seno H; Chiba T; Oshima M; Hsieh CL; Taketo MM
Oncogene; 2007 May; 26(24):3511-20. PubMed ID: 17160019
[TBL] [Abstract][Full Text] [Related]
7. PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells.
Raab M; Sanhaji M; Matthess Y; Hörlin A; Lorenz I; Dötsch C; Habbe N; Waidmann O; Kurunci-Csacsko E; Firestein R; Becker S; Strebhardt K
Nat Commun; 2018 Mar; 9(1):1106. PubMed ID: 29549256
[TBL] [Abstract][Full Text] [Related]
8. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice.
Oshima H; Oshima M; Kobayashi M; Tsutsumi M; Taketo MM
Cancer Res; 1997 May; 57(9):1644-9. PubMed ID: 9135000
[TBL] [Abstract][Full Text] [Related]
9. Colonic tumorigenesis in BubR1+/-ApcMin/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability.
Rao CV; Yang YM; Swamy MV; Liu T; Fang Y; Mahmood R; Jhanwar-Uniyal M; Dai W
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4365-70. PubMed ID: 15767571
[TBL] [Abstract][Full Text] [Related]
10. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
Li Q; Ishikawa TO; Oshima M; Taketo MM
Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
[TBL] [Abstract][Full Text] [Related]
11. CDX2 has tumorigenic potential in the human colon cancer cell lines LOVO and SW48.
Dang LH; Chen F; Ying C; Chun SY; Knock SA; Appelman HD; Dang DT
Oncogene; 2006 Apr; 25(15):2264-72. PubMed ID: 16314840
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice.
Hulit J; Wang C; Li Z; Albanese C; Rao M; Di Vizio D; Shah S; Byers SW; Mahmood R; Augenlicht LH; Russell R; Pestell RG
Mol Cell Biol; 2004 Sep; 24(17):7598-611. PubMed ID: 15314168
[TBL] [Abstract][Full Text] [Related]
13. Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation.
Lorentz O; Duluc I; Arcangelis AD; Simon-Assmann P; Kedinger M; Freund JN
J Cell Biol; 1997 Dec; 139(6):1553-65. PubMed ID: 9396760
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice.
Fujishita T; Aoki K; Lane HA; Aoki M; Taketo MM
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13544-9. PubMed ID: 18768809
[TBL] [Abstract][Full Text] [Related]
15. Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling.
Arimura S; Matsunaga A; Kitamura T; Aoki K; Aoki M; Taketo MM
Gastroenterology; 2009 Aug; 137(2):629-38. PubMed ID: 19427313
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin inhibition of polyposis and progression to dysplasia in a mouse model.
Hardiman KM; Liu J; Feng Y; Greenson JK; Fearon ER
PLoS One; 2014; 9(4):e96023. PubMed ID: 24763434
[TBL] [Abstract][Full Text] [Related]
17. Loss of a single Hic1 allele accelerates polyp formation in Apc(Δ716) mice.
Mohammad HP; Zhang W; Prevas HS; Leadem BR; Zhang M; Herman JG; Hooker CM; Watkins DN; Karim B; Huso DL; Baylin SB
Oncogene; 2011 Jun; 30(23):2659-69. PubMed ID: 21297660
[TBL] [Abstract][Full Text] [Related]
18. Cdx1 and Cdx2 function as tumor suppressors.
Hryniuk A; Grainger S; Savory JG; Lohnes D
J Biol Chem; 2014 Nov; 289(48):33343-54. PubMed ID: 25320087
[TBL] [Abstract][Full Text] [Related]
19. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.
Majumder PK; Febbo PG; Bikoff R; Berger R; Xue Q; McMahon LM; Manola J; Brugarolas J; McDonnell TJ; Golub TR; Loda M; Lane HA; Sellers WR
Nat Med; 2004 Jun; 10(6):594-601. PubMed ID: 15156201
[TBL] [Abstract][Full Text] [Related]
20. Suppressing TGFβ signaling in regenerating epithelia in an inflammatory microenvironment is sufficient to cause invasive intestinal cancer.
Oshima H; Nakayama M; Han TS; Naoi K; Ju X; Maeda Y; Robine S; Tsuchiya K; Sato T; Sato H; Taketo MM; Oshima M
Cancer Res; 2015 Feb; 75(4):766-76. PubMed ID: 25687406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
